- ISIN
- US45333L1061
- Sector
- Healthcare
- IPO Date
- Mar 2, 2022
Highlights
- Market Cap
- $40.13M
- Enterprise Value
- -$34.20M
- EPS (TTM)
- -$4.36
- Total Revenue (TTM)
- $66.62K
- Gross Profit (TTM)
- -$128.37K
- EBITDA (TTM)
- -$53.24M
- Year Range
- $2.49 - $49.80
- ROA (TTM)
- -62.21%
- ROE (TTM)
- -66.38%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IXHL Performance Chart
Incannex Healthcare Ltd ADR (IXHL) is down 69.7% since the beginning of the year. At $3 per share, IXHL is trading 93.5% below its 52-week high of $50.
Loading charts...
Returns By Period
Incannex Healthcare Ltd ADR (IXHL) has returned -69.74% so far this year and -50.56% over the past 12 months.
Incannex Healthcare Ltd ADR
- 1D
- -8.71%
- 1M
- -7.67%
- YTD
- -69.74%
- 6M
- -75.53%
- 1Y
- -50.56%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
IXHL Monthly Returns History
Based on dividend-adjusted daily data since Nov 30, 2023, IXHL's average daily return is +0.91%, while the average monthly return is -1.47%.
Historically, 34% of months were positive and 66% were negative. The best month was Jul 2025 with a return of +171.2%, while the worst month was Apr 2025 at -78.2%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, IXHL closed higher 42% of trading days. The best single day was May 14, 2025 with a return of +720.6%, while the worst single day was Apr 29, 2025 at -75.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.52% | -54.35% | -29.25% | 46.33% | -23.69% | -2.99% | -69.74% | ||||||
| 2025 | -21.23% | -23.95% | -46.73% | -78.15% | 42.08% | 2.71% | 171.21% | 12.65% | -29.54% | -18.80% | -4.46% | -0.61% | -83.11% |
| 2024 | -25.86% | 57.85% | -33.89% | -19.50% | -2.08% | 3.89% | -35.03% | -7.85% | 13.07% | 14.07% | -21.59% | 19.10% | -54.31% |
| 2023 | 104.87% | -41.93% | 18.97% |
Benchmark Metrics
Incannex Healthcare Ltd ADR has an annualized alpha of 837.81%, beta of 0.22, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 30, 2023.
- This stock participated in 401.19% of S&P 500 Index downside but only -8.91% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.22 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 837.81%
- Beta
- 0.22
- R²
- 0.00
- Upside Capture
- -8.91%
- Downside Capture
- 401.19%
Return for Risk
Risk / Return Rank
IXHL ranks 37 for risk / return — below 37% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Incannex Healthcare Ltd ADR (IXHL) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IXHL | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.31 | ||
| Sortino ratioReturn per unit of downside risk | -1.96 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.37 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.53 | 2.78 | -3.32 |
| Martin ratioReturn relative to average drawdown | -0.66 | 12.44 | -13.09 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Incannex Healthcare Ltd ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Incannex Healthcare Ltd ADR was 99.03%, occurring on May 12, 2025. The portfolio has not yet recovered.
The current Incannex Healthcare Ltd ADR drawdown is 98.76%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.03%May 2025 | 1y 5mo | — | 2y 6moDec 2023 - now |
2023 bear market2023 | -34.54%Dec 2023 | 0s | 4d | 4dDec 2023 - Dec 2023 |
Drawdown Indicators
| IXHL | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.03% | -56.78% | -42.25% |
Max Drawdown (1Y)Largest decline over 1 year | -94.76% | -9.10% | -85.66% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -98.76% | -1.80% | -96.96% |
Average DrawdownAverage peak-to-trough decline | -82.44% | -10.71% | -71.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 77.23% | 2.03% | +75.20% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Incannex Healthcare Ltd ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Incannex Healthcare Ltd ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IXHL relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IXHL has a P/S ratio of 558.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IXHL in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, IXHL has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IXHL
Add Incannex Healthcare Ltd ADR to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IXHL